Cargando…
Kinetic Optimization of Lysine-Targeting Covalent Inhibitors of HSP72
[Image: see text] The covalent inhibition mechanism of action, which overcomes competition with high-affinity, high-abundance substrates of challenging protein targets, can deliver effective chemical probes and drugs. The success of this strategy has centered on exposed cysteine residues as nucleoph...
Autores principales: | Pettinger, Jonathan, Carter, Michael, Jones, Keith, Cheeseman, Matthew D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2019
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6959841/ https://www.ncbi.nlm.nih.gov/pubmed/31725295 http://dx.doi.org/10.1021/acs.jmedchem.9b01709 |
Ejemplares similares
-
An Irreversible Inhibitor of HSP72 that Unexpectedly Targets Lysine‐56
por: Pettinger, Jonathan, et al.
Publicado: (2017) -
Coupling of HSP72 α-Helix Subdomains by the Unexpected Irreversible Targeting of Lysine-56 over Cysteine-17; Coevolution of Covalent Bonding
por: Aljoundi, Aimen, et al.
Publicado: (2020) -
Exploiting Protein
Conformational Change to Optimize
Adenosine-Derived Inhibitors of HSP70
por: Cheeseman, Matthew D., et al.
Publicado: (2016) -
Aryl Fluorosulfate Based Inhibitors That Covalently Target the SIRT5 Lysine Deacylase
por: Bolding, Julie E., et al.
Publicado: (2022) -
Targeting secondary protein complexes in drug discovery: studying the druggability and chemical biology of the HSP70/BAG1 complex
por: Evans, Lindsay E., et al.
Publicado: (2017)